PKM and malignant colon neoplasm: Zheng et al. reported that the long noncoding RNAs (lncRNAs) XIST could competitively bind to miR-137, thereby enhancing the PKM2 level and promoting chemoresistance in colon cancer cells (Zheng et al., 2021).